Biovico Sp. z o.o. Medical Biotech of Gdynia at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option
Manufacturers Trader

Biovico Sp. z o.o. Medical Biotech

Hutnicza 15B, 81061 Gdynia
Poland

Hall map

MEDICA 2019 hall map (Hall 15): stand D34

Fairground map

MEDICA 2019 fairground map: Hall 15

Contact

Katarzyna Cejrowska

Export Manager

Grzegorz Jemielita

Business Development Manager

Natalia Blewąska

Purchase Manager

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.05  Implants and protheses
  • 01.05.04  Other implants and protheses

Our products

Product category: Other implants and protheses

Biolevox™ HA 2.2%

Biolevox™ HA contains a high molecular weight sodium hyaluronate obtained by bacterial fermentation. This gel is used to improve viscosity of intra-articular connective tissues. Its lubricating and shock-absorbing properties enable pain-free physiological joint movements. It also participates in cartilage nutrition.
Biolevox™ HA is advised in case of pain and decreased articular mobility associated with degenerative and traumatic lesions of the knee and other synovial joints, including osteoarthritis.

More Less

Product category: Other implants and protheses

Biolevox™ One 2.5%

Biolevox™ One is intended to relieve knee pain and to improve articular mobility decreased due to degenerative knee lesions.
One of the highest content of HA in a single injection enables effective pain relief in a safe, quick and long-lasting term.
High molecular weight HA in one dose makes Biolevox™ ONE clinically more efficient and more resistant to enzymatic degradation than low molecular weight acids. Viscoelastic properties result in greater effectiveness of therapy and reduce number of injections.

More Less

Product category: Other implants and protheses

Xerthra™ PRP kit

Xerthra™ PRP kit – procedure pack for isolation and separation of platelet rich plasma (PRP) from patient's peripheral blood. Autologous PRP is a fraction of plasma with increased number of leukocytes which synthesize cytokines and higher amounts of platelets which release several types of growth factors for support tissue regeneration and healing processes.
Xerthra™ PRP kit guarantees uncomplicated, quick, and precise separation of highly concentrated (up to 12,6x) 1 ml of PRP with leukocytes from small amount of peripheral blood (15 ml with anticoagulant).
Xerthra™ PRP kit is recommended for use in the inflammatory phase of the disease when regenerative action of growth factors as well as regulatory action of leukocytes are required.

More Less

Product category: Other implants and protheses

Xerthra™ PRP PURE kit

Xerthra™ PRP PURE kit – procedure pack for isolation of plateletrich plasma with reduced content of leukocytes (LP-PRP) from the patient's peripheral blood. Autologous LP-PRP contains lower number of leukocytes and increased concentration of platelets rich in several growth factors which support healing of the injury over a shorter period of time with less side effects.
Xerthra™ PRP PURE kit guarantees uncomplicated, precise and convenient isolation of concentrated LP-PRP (1 ml) with reduced number of erythrocytes and leukocytes obtained via double centrifugation of freshly drawn peripheral blood (15 ml with anticoagulant).
LP-PRP is recommended for use in chronic, degenerative phase of the disease in which not inflammatory action of leukocytes but the regenerative action of growth factors contained in platelets is essential.

More Less

Product category: Other implants and protheses

Xerthra™ iPRF kit

Xerthra™ iPRF kit – procedure pack for isolation of injectable platelet-rich fibrin (iPRF) from the patient's peripheral blood. In the site of the injection autologous iPRF forms a fibrin network where leukocytes and platelets release cytokines and growth factors over a longer period of time.
Xerthra™ iPRF kit guarantees isolation from 15 ml of blood of large amount (1 to 6 ml) of iPRF. Adjustable amounts of iPRF allows for the individual approach to the patient needs and the use of the required volume. The obtained preparation remains in the liquid form up to 20 minutes (in 37°C) after preparation, which significantly prolongs the time of application to the target site and guarantees effective penetration into hard-to-reach places. Procedure does not require chemical modification of the blood by addition of the anticoagulant.
iPRF thanks to its unique ability for fibrin network creation is recommended to use in the injuries in which the prolongated regulatory as well as regenerative action of cytokines and growth factors is required.

More Less

Product category: Other implants and protheses

OSSYLBONE™

OSSYLBONE™ - finest  calcium phospates for better bone healing. These biomimetic bone grafts were designed for perfect bone healing, which is possible due to similarity in properties between product and natural bone.
* BIOcompatibile - ensures a biologically correct response of surrounding tissues;
* BIOactive - naturally stimulates material - bone tissue binding followed by bone growth;
* BIOdegradable - completely resorbed and replaced by a regenerating bone.
Available in a form of 3D structures, non-stetting and setting paste.

More Less

About us

Company details

Biovico is rapidly growing mid-size biotech company, with a strong legacy in the development of innovative products with a particular focus on biotechnology, orthopedics and regenerative medicine. The company consequently realizes its aims including introduction and development of effective preparations in field of pharmaceuticals and medical devices. From the year of establishment, the company has launched several medical devices in the area of orthopedics, rheumatology and neurology. Leader in the field of regenerative medicine (viscosupplementation, PRP therapy).

More Less

Company data

Foundation

2008